Final answer:
Topical antifungal medications like clotrimazole, miconazole, and nystatin are commonly used to treat vaginal candidiasis in pregnant women. Clotrimazole has been classified as a category B drug by the FDA, indicating safety in later stages of pregnancy. These treatments are highly successful with an 80-90% success rate.
Step-by-step explanation:
The three most common drugs given to women with CD (Candidiasis) during pregnancy primarily include topical antifungal medications, as systemic treatments are generally avoided to minimize potential risks to the developing fetus. The preferred treatments for vaginal candidiasis in pregnant women are:
- Clotrimazole
- Miconazole
- Nystatin
It is crucial to select the appropriate treatment during pregnancy due to safety concerns. Clotrimazole is classified as a category B drug by the FDA, which indicates that there is no evidence of harm in the second or third trimesters of pregnancy. Topical treatments like these have an 80-90% success rate in treating infections. However, medication choice may vary based on the individual patient's medical history and the pregnancy trimester.